Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Cancer Immunology, Immunotherapy : CII
Christiane MeyerDaniel E Speiser

Abstract

Metastatic melanoma has a poor prognosis with high resistance to chemotherapy and radiation. Recently, the anti-CTLA-4 antibody ipilimumab has demonstrated clinical efficacy, being the first agent to significantly prolong the overall survival of inoperable stage III/IV melanoma patients. A major aim of patient immune monitoring is the identification of biomarkers that predict clinical outcome. We studied circulating myeloid-derived suppressor cells (MDSC) in ipilimumab-treated patients to detect alterations in the myeloid cell compartment and possible correlations with clinical outcome. Lin(-) CD14(+) HLA-DR(-) monocytic MDSC were enriched in peripheral blood of melanoma patients compared to healthy donors (HD). Tumor resection did not significantly alter MDSC frequencies. During ipilimumab treatment, MDSC frequencies did not change significantly compared to baseline levels. We observed high inter-patient differences. MDSC frequencies in ipilimumab-treated patients were independent of baseline serum lactate dehydrogenase levels but tended to increase in patients with severe metastatic disease (M1c) compared to patients with metastases in skin or lymph nodes only (M1a), who had frequencies comparable to HD. Interestingly, clinic...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Feb 14, 2002·Scandinavian Journal of Immunology·X-B WangA K Lefvert
Sep 3, 2004·Nature Reviews. Immunology·Michal Baniyash
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Nov 23, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G ParmianiL Rivoltini
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paola FilipazziLicia Rivoltini
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hester van CruijsenTanja D de Gruijl
Sep 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chrysoula I LiakouPadmanee Sharma
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sergei KusmartsevJohannes Vieweg
Mar 24, 2009·Current Opinion in Immunology·Steven A Rosenberg, Mark E Dudley
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suzanne Ostrand-Rosenberg, Pratima Sinha
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susanna MandruzzatoPaola Zanovello
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
May 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bradley C CarthonPadmanee Sharma
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Aug 10, 2010·The Cancer Journal·Srinivas Nagaraj, Dmitry I Gabrilovich
Sep 8, 2010·The New England Journal of Medicine·Patrick Hwu
Nov 27, 2010·European Journal of Immunology·Alberto Mantovani
Dec 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Begoña Comin-AnduixAntoni Ribas
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Virginia A PedicordJames P Allison
Jan 18, 2011·International Immunopharmacology·Tim F GretenFirouzeh Korangy
Apr 6, 2011·Cancer Immunology, Immunotherapy : CII·Jianda YuanJedd D Wolchok
May 11, 2011·The Journal of Clinical Investigation·Lukas BaitschDaniel E Speiser
Jun 2, 2011·Nature Reviews. Drug Discovery·Vernon K SondakPeter Kirkpatrick
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jul 1, 2011·Immunologic Research·Hiam NaiditchGalina V Shurin
Sep 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jianda YuanSacha Gnjatic
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michele Del VecchioAndrea Anichini
Nov 26, 2011·Nature Reviews. Immunology·Lucy S K Walker, David M Sansom
Nov 29, 2011·Cancer Immunology, Immunotherapy : CII·Paola FilipazziLicia Rivoltini
Dec 8, 2011·Cancer Immunology, Immunotherapy : CII·Rui-Ru JiVafa Shahabi
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Jul 14, 2012·Journal of Translational Medicine·Wenshi WangJeffrey S Weber

❮ Previous
Next ❯

Citations

Feb 4, 2014·Cancer Immunology, Immunotherapy : CII·Serena ChangHolden T Maecker
Mar 25, 2014·Cancer Immunology, Immunotherapy : CII·Anke VanderstraetenFrederic Amant
Jun 27, 2014·Cancer Immunology, Immunotherapy : CII·Yago Pico de CoañaRolf Kiessling
Oct 24, 2014·Annual Review of Medicine·Thomas CondamineDmitry I Gabrilovich
Aug 11, 2015·Biochimica Et Biophysica Acta·Francesco De SanctisIlaria Marigo
Mar 12, 2016·Nature Reviews. Cancer·Sjoerd H van der BurgCornelis J M Melief
Feb 29, 2016·Current Oncology Reports·Claire F Friedman, Michael A Postow
Mar 8, 2016·Expert Opinion on Investigational Drugs·SeungJu Jackie OhA Craig Lockhart
Dec 5, 2014·European Journal of Immunology·Nathalie Auphan-Anezin, Anne-Marie Schmitt-Verhulst
Dec 8, 2014·Seminars in Radiation Oncology·Encouse B Golden, Lionel Apetoh
Dec 8, 2014·Seminars in Radiation Oncology·Ralph E Vatner, Silvia C Formenti
Jul 15, 2015·The Journal of Clinical Investigation·Douglas Marvel, Dmitry I Gabrilovich
Jun 21, 2015·Trends in Molecular Medicine·Yago Pico de CoañaRolf Kiessling
Jan 17, 2015·Journal of Translational Medicine·Ines ChevoletLieve Brochez
Jul 15, 2015·BioMed Research International·Ayumu ItoShigehisa Kitano
May 13, 2015·Seminars in Oncology·Benjamin WeideLaurence Zitvogel
Apr 11, 2015·Frontiers in Immunology·Florencia Paula Madorsky RowdoJosé Mordoh
Sep 3, 2014·Immunobiology·Anton A Keskinov, Michael R Shurin
Nov 30, 2014·Cancer Immunology, Immunotherapy : CII·Michelle N MessmerScott I Abrams
Jul 20, 2014·International Immunology·Christian U Blank, Alexander Enk
May 30, 2016·Cellular and Molecular Life Sciences : CMLS·Christopher ShippGraham Pawelec
Jun 16, 2016·Journal of Dermatological Science·Kenta Nakamura, Ryuhei Okuyama
Sep 14, 2016·Oncoimmunology·Nienke de HaasStanleyson V Hato
Jul 11, 2016·Cancer Treatment Reviews·Gongda XueMario Mandalà
Jul 12, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kilian Wistuba-HamprechtBenjamin Weide
Nov 10, 2016·Vaccines·Viktor UmanskyJochen Utikal
Nov 10, 2016·Vaccines·Chiara CamisaschiVeronica Huber
Nov 26, 2016·International Journal of Molecular Sciences·Gabor J SzebeniLaszlo G Puskas
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckDavid Spigel
Apr 7, 2017·Pediatric Blood & Cancer·John Anderson
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Meng Shen, Xiubao Ren
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suzanne Ostrand-Rosenberg, Catherine Fenselau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.